Axecap Investments’s Cardinal Health CAH Stock Holding History

Axecap Investments’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,545	Closed	-$3.28M	–	76
2026 Q1	$3.28M	Buy	15,545 +4,005	+35%	+$862K	2.26%	18
2025 Q4	$2.37M	Buy	+11,540	New	+$2.17M	1.46%	29

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Axecap Investments's CAH Position: Q2 2026 in Review

Axecap Investments sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 15,545 shares — an estimated $3.28M sold.

Axecap Investments first reported a position in CAH in Q4 2025 and held it in 2 quarters. The position peaked at $3.28M in Q1 2026. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Axecap Investments reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
Axecap Investments sold 15,545 Cardinal Health shares in Q2 2026, an estimated $3.28M.
Axecap Investments first reported a position in Cardinal Health in Q4 2025 and held it in 2 quarters.
Axecap Investments's Cardinal Health position peaked at $3.28M in Q1 2026.
1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Axecap Investments's 13F filing for Q2 2026, filed 10 Aug 2026.